» Articles » PMID: 25714070

Plasma Nuclear and Mitochondrial DNA Levels in Acute Myocardial Infarction Patients

Overview
Date 2015 Feb 26
PMID 25714070
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Plasma nuclear and mitochondrial DNA (mtDNA) levels are altered in many diseases. However, it is not known whether they are also altered in acute myocardial infarction (AMI). In the present study, we examined plasma nuclear and mtDNA levels in the patients with AMI before and after a percutaneous coronary intervention (PCI) to explore their potential as biomarkers.

Methods And Results: Plasma nuclear and mtDNA levels were measured by quantitative PCR in 25 AMI patients, 25 non-myocardial infarction (MI) control participants (with MI risk), and 20 healthy individuals during the study period. The concentrations of nuclear and mtDNA were significantly higher in the AMI group on hospital day 1 than that in the non-MI controls (nuclear: 0.4948±0.0830 vs. 0.2047±0.0222 ng/μl, P<0.05; mitochondrial: 3.754±0.384 vs. 1.851±0.3483 ng/μl, P<0.05) and healthy individuals (nuclear: 0.4948±0.0830 vs. 0.1683±0.0254 ng/μl, P=0.001; mitochondrial: 3.754±0.384 vs. 0.1517±0.0924 ng/μl, P<0.05) and decreased shortly after PCI.

Conclusion: Both plasma nuclear and mtDNA levels are elevated in AMI patients, but return to normal levels immediately after PCI, suggesting that they are potentially novel biomarkers for AMI.

Citing Articles

Disruption of mitochondrial DNA integrity in cardiomyocyte injury upon ischemia/reperfusion.

Hu S, Tang X, Zhu F, Liang C, Wang S, Wang H Genes Dis. 2025; 12(3):101282.

PMID: 40028034 PMC: 11870174. DOI: 10.1016/j.gendis.2024.101282.


Correlation between circulating cell-free mitochondrial DNA content and severity of knee degeneration in patients with knee osteoarthritis: a cross-sectional study.

Wu Y, Wan S, Long Y, Ye H, Yang J, Luo Y Arthritis Res Ther. 2024; 26(1):202.

PMID: 39558418 PMC: 11571657. DOI: 10.1186/s13075-024-03438-y.


Cell-free DNA as a potential biomarker for acute myocardial infarction: A systematic review and meta-analysis.

Tan E, Liu D, Perry L, Zhu J, Cid-Serra X, Deane A Int J Cardiol Heart Vasc. 2023; 47:101246.

PMID: 37560328 PMC: 10407200. DOI: 10.1016/j.ijcha.2023.101246.


Liquid Biopsy in Coronary Heart Disease.

Zhu W, Li X Methods Mol Biol. 2023; 2695:279-293.

PMID: 37450126 DOI: 10.1007/978-1-0716-3346-5_19.


Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases.

Seok J, Kim M, Kang H, Cho Y, Lee H, Lee J Arch Pharm Res. 2023; 46(6):500-534.

PMID: 37354378 PMC: 10333371. DOI: 10.1007/s12272-023-01452-3.


References
1.
Penttila I, Penttila K, Rantanen T . Laboratory diagnosis of patients with acute chest pain. Clin Chem Lab Med. 2000; 38(3):187-97. DOI: 10.1515/CCLM.2000.027. View

2.
Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T . Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012; 485(7397):251-5. PMC: 3378041. DOI: 10.1038/nature10992. View

3.
Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K . Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 2001; 88(5):529-35. DOI: 10.1161/01.res.88.5.529. View

4.
Libby P . Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001; 104(3):365-72. DOI: 10.1161/01.cir.104.3.365. View

5.
Wu T, Tsao K, Sun C, Wu J . Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta. 2002; 327(1-2):95-101. DOI: 10.1016/s0009-8981(02)00337-6. View